Lead Product(s) : Entrectinib
Therapeutic Area : Oncology
Study Phase : Approved
Sponsor : Chugai Pharmaceutical
Deal Size : Undisclosed
Deal Type : Agreement
Thermo Fisher Signs CDx Agreement with Chugai Pharma
Details : Approval by the MHLW would accelerate access to Chugai's targeted therapy via a locally administered, next-generation sequencing (NGS) biomarker test.
Brand Name : Rozlytrek
Molecule Type : Small molecule
Upfront Cash : Undisclosed
July 08, 2020
Lead Product(s) : Entrectinib
Therapeutic Area : Oncology
Highest Development Status : Approved
Sponsor : Chugai Pharmaceutical
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?
Reset All
